Ghana is grappling with a $78.2 million shortfall in health funding following the suspension of USAID programmes, jeopardising immunisation services that had helped reduce child mortality — including through the RTS,S malaria vaccine, which was linked to a 13 percent drop in deaths among eligible children in Ghana, Kenya, and Malawi. The funding gap has disrupted vaccine supply chains, with a study in northern Ghana finding that 75 percent of surveyed districts reported vaccine delays or irregular supplies, with particular concern in remote areas such as the Oti Region (a sparsely populated district near Ghana's northern borders). The crisis comes as Ghana simultaneously navigates a scheduled transition away from Gavi (the Vaccine Alliance) support by 2030, prompting calls from health officials and civil society groups for greater domestic financing, private sector investment, and community-led resource mobilisation to safeguard gains that took years to build.